Explore more publications!

Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on October 1, 2025

Therapist and Author Offers Insights into How Thinking Differently About Time Can Lead to Breakthroughs in Healing
Advocates mark World Meningitis Day with launch of new video series to support awareness and prevention efforts
Richmond Health Care Center Achieves Deficiency-Free State Survey
CompuGroup Medical Named 2025 Surescripts White Coat Award Winner
Cravey Real Estate Services Brokers Sale of Modern 47,950 SF Corpus Christi Senior Care Facility
Visory Health genera ahorros de 790 millones de dólares en medicamentos cardiovasculares esenciales
New Imprivata Report Finds that Australian Hospitals Save More Than $1.2 Million AUD Annually with Shared-Use Mobile Devices, but Strategic Gaps Still Pose Security and Operational Risk
San Antonio’s Doc Blackstone Modernizes Acupuncture: 5000-Year Practice Now Needle-Free, Solving Rare Cases
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TOMI Environmental Solutions Appoints Harold W. Paul to Its Board of Directors
Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine
Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer
NANOBIOTIX annonce les premières données de Phase 1 évaluant JNJ-1900 (NBTXR3) chez des patients atteints de cancer de l’œsophage
Vital Nutrients Expands Clinical Line With New Formula for Women’s Hair Health
POP Biotechnologies Awarded $2.46M NIH Grant for Alzheimer's Immunotherapy
Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference
Venus Concept to Release Third Quarter of Fiscal Year 2025 Financial Results on November 13, 2025
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025
George Paletta, Jr., MD, MBA, Internationally Acclaimed Entrepreneur, Investor and Surgeon, Elected to Longeveron® Board of Directors

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions